Granahan Investment Management’s Affimed AFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-383,955
Closed -$4.76M 166
2022
Q4
$4.76M Sell
383,955
-144
-0% -$2.53K 0.15% 134
2022
Q3
$7.91M Sell
384,099
-6,086
-2% -$169K 0.26% 103
2022
Q2
$10.8M Buy
390,185
+136,492
+54% +$4.67M 0.37% 79
2022
Q1
$11.1M Sell
253,693
-84,245
-25% -$3.66M 0.28% 85
2021
Q4
$18.7M Buy
337,938
+268
+0.1% +$16.6K 0.38% 70
2021
Q3
$20.9M Sell
337,670
-29,960
-8% -$1.97M 0.4% 61
2021
Q2
$31.2M Buy
367,630
+29,156
+9% +$2.66M 0.58% 45
2021
Q1
$26.8M Buy
338,474
+157,457
+87% +$10.2M 0.57% 45
2020
Q4
$10.5M Buy
+181,017
New +$8.52M 0.24% 89

Other funds holding AFMD

Granahan Investment Management's AFMD Position: Q1 2023 in Review

Granahan Investment Management sold out of Affimed (AFMD) in Q1 2023, closing a stake of 383,955 shares — an estimated $4.76M sold.

Granahan Investment Management first reported a position in AFMD in Q4 2020 and held it in 9 quarters. The position peaked at $31.2M in Q2 2021. 94 funds tracked by Wall St. Rank hold AFMD as of Q1 2023.

  • Granahan Investment Management reported no remaining Affimed position as of Q1 2023 after selling out during the quarter.
  • Granahan Investment Management sold 383,955 Affimed shares in Q1 2023, an estimated $4.76M.
  • Granahan Investment Management first reported a position in Affimed in Q4 2020 and held it in 9 quarters.
  • Granahan Investment Management's Affimed position peaked at $31.2M in Q2 2021.
  • 94 funds tracked by Wall St. Rank held Affimed as of Q1 2023.

Based on Granahan Investment Management's 13F filing for Q1 2023, filed 15 May 2023.